1. 58: SARS-COV-2 ANTIBODY CHARACTERISTICS OF SALIVA FROM VACCINATED INDIVIDUALS. (December 2022) Authors: Ota, K.; Mitsumoto-Kaseida, F.; Sakamoto, K.; Kosai, K.; Hasegawa, H.; Yamamoto, K.; Izumikawa, K.; Mukae, H.; Kohno, S.; Yanagihara, K. Journal: Journal of global antimicrobial resistance Issue: Volume 31(2022)Supplement 1 Page Start: S34 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. IL‐15 is a biomarker involved in the development of rapidly progressive interstitial lung disease complicated with polymyositis/dermatomyositis. (21st July 2020) Authors: Shimizu, T.; Koga, T.; Furukawa, K.; Horai, Y.; Fujikawa, K.; Okada, A.; Okamoto, M.; Endo, Y.; Tsuji, S.; Takatani, A.; Umeda, M.; Fukui, S.; Sumiyoshi, R.; Kawashiri, S.‐y.; Iwamoto, N.; Igawa, T.; Ichinose, K.; Tamai, M.; Sakamoto, N.; Nakamura, H. Journal: Journal of internal medicine Issue: Volume 289:Number 2(2021) Page Start: 206 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Raloxifene improves arterial stiffness and the carotid IMT progression in postmenopausal osteopenia/osteoporosis women over 12 months. Issue 1 (July 2015) Authors: Okada, K.; Furusyo, N.; Kainuma, M.; Ogawa, E.; Mukae, H.; Toyoda, K.; Murata, M.; Hayashi, J. Journal: Atherosclerosis Issue: Volume 241:Issue 1(2015) Page Start: e145 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Serum WFA+‐M2BP is a non‐invasive liver fibrosis marker that can predict the efficacy of direct‐acting anti‐viral‐based triple therapy for chronic hepatitis C. Issue 1 (26th October 2015) Authors: Ura, K.; Furusyo, N.; Ogawa, E.; Hayashi, T.; Mukae, H.; Shimizu, M.; Toyoda, K.; Murata, M.; Hayashi, J. Journal: Alimentary pharmacology & therapeutics Issue: Volume 43:Issue 1(2016) Page Start: 114 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Subclinical carotid atherosclerosis predicts the incidence of chronic kidney disease in a Japanese general population. Issue 1 (July 2015) Authors: Shimizu, M.; Furusyo, N.; Mitsumoto, F.; Takayama, K.; Ura, K.; Hiramine, S.; Ikezaki, H.; Ihara, T.; Mukae, H.; Ogawa, E.; Toyoda, K.; Kainuma, M.; Murata, M.; Hayashi, J. Journal: Atherosclerosis Issue: Volume 241:Issue 1(2015) Page Start: e64 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Subclinical carotid atherosclerosis predicts the incidence of chronic kidney disease in a Japanese general population. Issue 1 (July 2015) Authors: Shimizu, M.; Furusyo, N.; Mitsumoto, F.; Takayama, K.; Ura, K.; Hiramine, S.; Ikezaki, H.; Ihara, T.; Mukae, H.; Ogawa, E.; Toyoda, K.; Kainuma, M.; Murata, M.; Hayashi, J. Journal: Atherosclerosis Issue: Volume 241:Issue 1(2015) Page Start: e64 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. The effectiveness of meropenem and amikacin combination therapy against Carbapenemase-producing Klebsiella pneumoniae pneumonia mouse model. (December 2020) Authors: Ota, K.; Kaku, N.; Uno, N.; Sakamoto, K.; Morinaga, Y.; Hasegawa, H.; Miyazaki, T.; Izumikawa, K.; Mukae, H.; Yanagihara, K. Journal: International journal of infectious diseases Issue: Volume 101(2020)Supplement 1 Page Start: 6 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗